Robb Gary Charles's Form 4 filing
Corcept Therapeutics Inc (CORT) · filed May 22, 2025
- Accession no.
- 0000950170-25-076417
- Filed
- May 22, 2025
- Trade date
- May 20, 2025
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 4 non-derivative transactions. Open-market sales total $172.9K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Robb Gary CharlesCIK 0001529655 | Officer (Chief Business Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 20, 2025 | Common Stock | SSaleDisposed | −2,279 | $75.85 | −$172,862.15 | 16,586 | Direct | |
| May 20, 2025 | Common Stock | GGiftDisposed | −1,380 | $0.00 | $0 | 15,206 | Direct | |
| May 20, 2025 | Common Stock | GGiftAcquired | +360 | $0.00 | $0 | 11,571 | Indirect | |
| May 20, 2025 | Common Stock | GGiftAcquired | +360 | $0.00 | $0 | 11,571 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.
Remarks
The power of attorney under which this form was signed is on file with the Commission.